EMPLIMET XR 2.5/12.5/1000MG TAB

EMPLIMET XR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 2.5mg, Linagliptin 12.5mg, and Metformin 1000mg—three powerful ingredients working together to help control blood sugar levels. Empagliflozin helps your kidneys remove excess glucose through urine, while Linagliptin enhances insulin secretion and reduces glucagon levels. Metformin improves insulin sensitivity and reduces glucose production in the liver. This synergistic combination offers effective glycemic control in a single extended-release formulation. EMPLIMET XR is ideal for patients with type 2 diabetes who require multi-drug therapy. The extended-release formula ensures consistent medication levels throughout the day, improving compliance and convenience. Take as directed by your healthcare provider for optimal results in managing your diabetes.